[Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Ortner
M
M
IV. Medizinische Klinik/Poliklinik, Universitätsklinikum Charité, Berlin.
Lochs
H
H
D000368:Aged; D000369:Aged, 80 and over; D000622:Aminolevulinic Acid / Q000627:therapeutic use*; D001471:Barrett Esophagus / Q000188:drug therapy* / Q000473:pathology; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004947:Esophagus / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000378:metabolism*; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000473:pathology; D011524:Protoporphyrins / Q000378:metabolism*
D017319:Photosensitizing Agents; D011524:Protoporphyrins; D000622:Aminolevulinic Acid; C028025:protoporphyrin IX
Eradikation der hochgradigen Dysplasie bei Barrett-Osophagus durch photodynamische Therapie mit endogen erzeugtem Protoporphyrin IX.